Biogen
$182.98
24H
Market Cap
Volume
Supply
Price Chart
About Biogen - BIIB
Biogen Inc. is a multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of neurological and neurodegenerative diseases. Some of their most notable products include treatments for multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease.
What are Biogen's core values and mission statement?
Biogen Inc.'s mission statement emphasizes discovering, developing, and delivering innovative therapies for people living with serious neurological and neurodegenerative diseases. The company upholds core values centered on pioneering science, inclusion and diversity, and making a positive impact on patients and their communities.
Who founded Biogen and when?
Biogen Inc. was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel laureates Walter Gilbert and Phillip Sharp.
Who leads Biogen?
As of my last update, Michel Vounatsos is the CEO of Biogen Inc.
Where is Biogen located, and what is its base country?
Biogen Inc. is headquartered in Cambridge, Massachusetts, United States. Its base country is the United States.
On which exchanges is Biogen traded?
Biogen Inc. is primarily listed on the NASDAQ stock exchange under the ticker symbol "BIIB".
Historical data
Biogen (BIIB) Price Live Data
The live price of Biogen (BIIB) is $182.98, with a trading volume of 973,595 in the last 24 hours. Wrapstocks updates the BIIB price in real-time. Biogen is down -1.57% in the last 24 hours. The company has a live market cap of $26,653,233,152.00 and a supply of 145,662,002 BIIB stocks.
Biogen (BIIB) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 8 hours and 31 minutes.
